Funding & M&A 20 Oct 2026 · OpenAI · Global · Impact 3/5 ●●●○○

OpenAI acquires Orchestra Bio

Why it matters to executives

  1. Drug-development coordination platform joins OpenAI's Rosalind life-sciences effort.
  2. OpenAI going vertical in pharma.
  3. Pharma execs: model vendors are now competitors as well as suppliers.

Sources

Related

The monthly memo

The top 10 AI developments, one chart and one decision for your agenda. Free, monthly, a five-minute read.

Subscribe free (opens soon)

← Back to the tracker